Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jan 1;2(1):63-74.
doi: 10.2174/1874471010902010063.

Propargyl 4-[F]fluorobenzoate: A Putatively More Stable Prosthetic group for the Fluorine-18 Labeling of Biomolecules via Click Chemistry

Affiliations

Propargyl 4-[F]fluorobenzoate: A Putatively More Stable Prosthetic group for the Fluorine-18 Labeling of Biomolecules via Click Chemistry

Ganesan Vaidyanathan et al. Curr Radiopharm. .

Abstract

Faster and more efficient approaches for radiolabeling biomolecules with short-lived (18)F are in dire need. Herein we report a new (18)F-labeled prosthetic group containing an acetylene function that permits the labeling of biomolecules via click chemistry. This template, propargyl 4-[(18)F]fluorobenzoate ([(18)F]PFB) was synthesized from a quaternary salt precursor in decay-corrected radiochemical yields of 58 +/- 31%. Several model compounds containing an azide moiety-benzyl azide, two lysine derivatives and a transglutaminase-reactive peptide-were labeled using [(18)F]PFB via a click reaction in decay-corrected radiochemical yields of 88 +/- 4%, 79 +/- 33%, 75 +/- 5%, and 37 +/- 31%, respectively. Our results suggest that the novel agent [(18)F]PFB is a potentially useful template for the (18)F-labeling of biomolecules via click chemistry.

PubMed Disclaimer

Figures

Fig. (1)
Fig. (1)
A typical HPLC profile of the reaction mixture from the synthesis of propargyl 4-[18F]fluorobenzoate ([18F]1).
Fig. (2)
Fig. (2)
Radio thin layer chromatography profile of the reaction mixture from the synthesis of propargyl 4-[18F]fluorobenzoate ([18F]1).
Fig. (3)
Fig. (3)
HPLC of reaction mixture from the preparation of [18F]1 before and after treatment with polystyrene-bound sulfonic acid. Reaction mixture was reconstituted in THF as described in the text and a 10 :L aliquot was injected onto HPLC (left panel). Then the THF solution was treated with the sulfonic acid derivative for 1 h and 10 :L aliquot was injected again (right panel). Note the disappearance of the peak corresponding to compound 2 pointed out by arrows.
Fig. (4)
Fig. (4)
HPLC profile of the click reaction between azidohexanoyl-YQSIYVPDI and [18F]1.
Scheme 1
Scheme 1
Synthesis of unlabeled and 18F-labeled propargyl 4-fluorobenzoate (1) and its quaternary salt precursor, 4-propargyloxycarbonyl N, N, N-trimethylanilinium trifluoromethanesulfonate (3).
Scheme 2
Scheme 2
Synthesis of unlabeled and 18F-labeled (1-benzyl-1H-1,2,3-triazol-4-yl)methyl 4-fluorobenzoate.
Scheme 3
Scheme 3
Synthesis of 6-amino-2-(4-azidobenzamido)hexanoic acid (7) and, labeled and unlabeled 1-[4-(5-amino-1-carboxy-pentylcarbamoyl)-phenyl]-1H-[1,2,3]triazol-4-ylmethyl 4-fluorobenzoate (8).
Scheme 4
Scheme 4
Synthesis of 6-amino-2-(6-azidohexamido)hexanoic acid (11) and, labeled and unlabeled 1-[5-(5-amino-1-carboxy-pentylcarbamoyl)-pentyl]-1H-[1,2,3]triazol-4-ylmethyl 4-fluorobenzoate (12).
Scheme 5
Scheme 5
Synthesis of labeled and unlabeled 14.

References

    1. Weissleder R. Molecular imaging in cancer. Science. 2006;312:1168–71. - PubMed
    1. Kelloff GJ, Krohn KA, Larson SM, Weissleder R, Mankoff DA, Hoffman JM, Link JM, Guyton KZ, Eckelman WC, Scher HI, O’Shaughnessy J, Cheson BD, Sigman CC, Tatum JL, Mills GQ, Sullivan DC, Woodcock J. The progress and promise of molecular imaging probes in oncologic drug development. Clin Cancer Res. 2005;11:7967–85. - PubMed
    1. Rudin M, Weissleder R. Molecular imaging in drug discovery and development. Nat Rev Drug Discov. 2003;2:123–31. - PubMed
    1. Sparreboom A. Unexplored pharmacokinetic opportunities with microdosing in oncology. Clin Cancer Res. 2007;13:4033–4. - PubMed
    1. Singh SS. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs. Curr Drug Metab. 2006;7:165–82. - PubMed

LinkOut - more resources